Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

“…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”

AICD transgenic mice show decreased cell proliferation in the SGZ of hippocampus. by Kaushik Ghosal (244754)

“…(<b>A–B</b>) At 1.5 mo there was no statistically significant difference in the number of BrdU-labeled cells between wild-type and FeCγ25 mice, quantified in (<b>B</b>). …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

S5 Fig - by R. J. S. D. Heine (17889199)

Fli-1 directly activates miR-17-92 promoter and contributes to miR-17 and miR-20a expression in NN10#5 cells. by Samer Kayali (133888)

“…<p>A: NN10#5 cells have been cultured for two days in absence or presence of Dox used to induce Fli-1 knock-down before analysis. …”

Fig 5 - by Melissa K. Peckins (12042132)

<i>k_i</i> impacts on<i>V</i>^<i>C</i>(<i>W</i>). by Yan Zhao (58882)

<i>μ_G</i> impacts on <i>V</i>^<i>C</i>(<i>W</i>). by Yan Zhao (58882)

Expression and stability of EspA are decreased in the absence of <i>escA.</i> by Ching-Nan Lin (508587)

The field sensitivity of a pyramidal cell decreases in a high-conductance state. by Florian Aspart (3366014)

TG mice hearts show decreased ISO response. by Mayilvahanan Shanmugam (691549)

DBcAMP and glucagon produces a decrease of peripheral insulin sensitivity. by Rita S. Patarrão (737406)

BECN1 knockdown and BCL-W/BCL2 co-inhibition decreases cell proliferation through increased apoptosis in resistant cells. by Anatasha C. Crawford (255140)

Overexpression of Tdp2 was associated with a decrease in HBV CCC DNA. by Xiuji Cui (755449)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Associations between characteristics of Stories for Change Diabetes participants and meaningful decrease in hemoglobin A1c (HbA1c) from baseline to 3 months (N = 227).^a... by Abby M. Lohr (11263772)

Subjects:

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Specificity of ChR2-YFP expression in DRN 5-HT neurons and efficiency of photostimulation <i>in vitro</i>. by Guillaume P. Dugué (620333)